NM_001399737.1:c.-135+11296T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001399737.1(CTNNA2):c.-135+11296T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.437 in 151,948 control chromosomes in the GnomAD database, including 16,193 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.44 ( 16193 hom., cov: 32)
Consequence
CTNNA2
NM_001399737.1 intron
NM_001399737.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.934
Publications
1 publications found
Genes affected
CTNNA2 (HGNC:2510): (catenin alpha 2) Enables actin filament binding activity. Involved in negative regulation of Arp2/3 complex-mediated actin nucleation; regulation of neuron migration; and regulation of neuron projection development. Located in cytoplasm. Implicated in complex cortical dysplasia with other brain malformations. [provided by Alliance of Genome Resources, Apr 2022]
CTNNA2 Gene-Disease associations (from GenCC):
- cortical dysplasia, complex, with other brain malformations 9Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.654 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CTNNA2 | NM_001399737.1 | c.-135+11296T>C | intron_variant | Intron 4 of 21 | NP_001386666.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.437 AC: 66307AN: 151830Hom.: 16165 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
66307
AN:
151830
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.437 AC: 66380AN: 151948Hom.: 16193 Cov.: 32 AF XY: 0.443 AC XY: 32880AN XY: 74266 show subpopulations
GnomAD4 genome
AF:
AC:
66380
AN:
151948
Hom.:
Cov.:
32
AF XY:
AC XY:
32880
AN XY:
74266
show subpopulations
African (AFR)
AF:
AC:
27360
AN:
41428
American (AMR)
AF:
AC:
6304
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
AC:
928
AN:
3470
East Asian (EAS)
AF:
AC:
2543
AN:
5120
South Asian (SAS)
AF:
AC:
2042
AN:
4812
European-Finnish (FIN)
AF:
AC:
4787
AN:
10568
Middle Eastern (MID)
AF:
AC:
141
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21048
AN:
67970
Other (OTH)
AF:
AC:
901
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1759
3518
5278
7037
8796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
598
1196
1794
2392
2990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1662
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.